The Indonesia AIDS Coalition (IAC) and Indonesia for Global Justice (IGJ) have filed a patent opposition for the Tuberculosis (TB) drug Bedaquiline with dispersible tablet formulations (hereinafter, in the context of this article, will be referred to as ‘Bedaquiline’). The patent opposition was filed to the Patent Appeal Commission, Directorate General of Intellectual Property (DGIP), Ministry of Law and Human Rights. The patent opposition was submitted in November 2022 and was rejected by a decision from the Judiciary Panel on November 9th, 2023. Read more here.
top of page
Recent Posts
See AllThis report marks the midway point of the 1/4/6×24 Campaign, which calls for the universal implementation of the best available TB regimens — as little as one month or once weekly for TB prevention, f
40
Their annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB). View the full
60
Calls for strengthening health systems in preparation for the next pandemic have intensified in the wake of COVID-19, with estimates ranging from $15 billion to $50 billion needed annually to scale up
570
bottom of page